Mike (left) and Richard Pazdur, M.D., director of the FDA's division of oncology drug products, listen to Andrew Von Eschenbach, director of the National Cancer Institute (NCI) during the Prostate Cancer Foundation's 2002 Scientific Retreat. Both Mike and Von Eschenbach advocated a systems approach to cancer research and the search for a cure, requiring a close working relationship between the NCI and academic and private researchers.